NCT03301857 2024-05-20Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004AmgenPhase 4 Completed85 enrolled 13 charts
NCT00396279 2022-11-08Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of BoneAmgenPhase 2 Completed37 enrolled 13 charts
NCT00680992 2022-09-22Study of Denosumab in Subjects With Giant Cell Tumor of BoneAmgenPhase 2 Completed535 enrolled 16 charts
NCT00464620 2018-11-23Trial of Dasatinib in Advanced SarcomasSarcoma Alliance for Research through CollaborationPhase 2 Completed366 enrolled 16 charts